First Unfold AI®-Assisted Focal One Procedures Successfully Performed at UCLA School of Medicine
Introduction
EDAP TMS SA and Avenda Health have teamed up to bring groundbreaking technology to the field of prostate cancer treatment. The collaboration agreement between the two companies focuses on providing personalized care for prostate cancer patients using Avenda Health’s innovative AI technology, Unfold AI. This technology has enabled the successful completion of the first AI-assisted Focal One robotic high-intensity focused ultrasound (HIFU) procedures at the prestigious UCLA School of Medicine.
Unfold AI: Revolutionizing Cancer Care
Unfold AI, developed by Avenda Health, is a multimodal AI decision support platform that has been cleared by the FDA. This platform empowers urologists to deliver tailored, patient-specific robotic HIFU ablation for prostate cancer patients. With its “superhuman” abilities, Unfold AI is paving the way for the future of cancer care by providing surgeons and oncologists with advanced tools for better treatment outcomes.
Impact on the Medical Community
The successful performance of Unfold AI-assisted procedures at UCLA School of Medicine marks a significant milestone in the field of cancer treatment. The use of AI technology in healthcare has the potential to revolutionize the way diseases are diagnosed and treated, leading to more personalized and effective care for patients.
Presentation at the Focal Therapy Society & Society of Urologic Robotic Surgeons Meeting
EDAP and Avenda Health will be presenting Unfold AI-assisted Focal One simulated procedures at the 2024 Joint Meeting of the Focal Therapy Society & Society of Urologic Robotic Surgeons in Washington, DC. This event will showcase the capabilities of Unfold AI and its potential impact on the future of cancer treatment.
How This Technology Will Affect Individuals
For individuals, the use of Unfold AI in cancer treatment means more personalized and tailored care. With AI technology assisting in diagnosis and treatment planning, patients can expect better outcomes and potentially faster recovery times. This innovative approach to healthcare could improve the quality of life for those undergoing cancer treatment.
Global Impact of Unfold AI
On a global scale, the adoption of Unfold AI in cancer care could lead to more efficient and cost-effective treatment options. By leveraging AI technology, healthcare providers can optimize treatment plans and improve patient outcomes, ultimately reducing the burden of cancer on healthcare systems worldwide.
Conclusion
The collaboration between EDAP TMS SA and Avenda Health to bring Unfold AI to the field of prostate cancer treatment represents a significant advancement in healthcare technology. With its potential to revolutionize cancer care on both an individual and global scale, Unfold AI is poised to shape the future of cancer treatment and improve patient outcomes worldwide.
